期刊文献+

ECV304-SKOV3和L_(929)-H_(22)细胞协同形成血管样结构的体外研究 被引量:1

In vitro study on synergism of ECV304-SKOV3 and L_(929)-H_(22) cells in tumor angiogenesis
下载PDF
导出
摘要 目的:在建立肿瘤基质血管内皮细胞模型(ECV304-SKOV3)和成纤维细胞模型(L929-H22)的基础上,进一步探讨二者在肿瘤新生血管形成中的协同作用。方法:对ECV304-SKOV3和L929-H22细胞用RT-PCR测定其端粒酶活性,双室联合培养测定ECV304-SKOV3细胞游走与管腔形成能力、L929-H22细胞促进肿瘤细胞侵袭与内皮细胞管腔形成能力。结果:ECV304-SKOV3细胞和L929-H22细胞的端粒酶活性明显强于亲代细胞ECV304、L929,分别为0.778±0.011、0.875±0.026、0.692±0.014、0.684±0.012(P<0.001)。ECV304-SKOV3细胞较ECV304细胞的游走能力强2.10倍,差异非常显著(P<0.001),且管腔形成能力明显增强,管腔数多0.94倍(P<0.01),管腔长0.91倍(P<0.01)。L929-H22明显促进肿瘤细胞侵袭(P<0.001)与ECV304、ECV304-SKOV3细胞形成管型(P<0.05),尤其与ECV304-SKOV3联合培养时形成的管腔最多且最长(P<0.01;P<0.001)。结论:肿瘤基质血管内皮细胞存活能力、游走与管腔形成能力增强。肿瘤基质成纤维细胞明显促进肿瘤细胞侵袭与血管内皮细胞形成管型。二者在肿瘤新生血管形成中有协同作用。 Objective:To explore the synergism of vascular endothelial cells and fibroblasts derived from tumors in the tumor angiogenesis after the establishment of the cell models. Methods : Reverse transcription polymerase chain reaction, two - well co culture system were used to detect the tolomerase activity, and their abilities of migration and angiogenesis of ECV304 - SKOV3 cells and the potential of L929 - H22 to promote angiogenesis and invasion of MDA MB 231 cells, respectively, which were established as the cell models for vascular endothelial cells and fibroblasts derived from tumors in our laboratory before. Results : Tolomerase activity level of ECV304 SKOV3 cells was higher than that of ECV304 cells (0. 778 ± 0.011 vs 0. 692 ± 0. 014, P 〈 0. 001 ), ,so were L929 - H22 cells and L929 cells (0. 875 ± 0. 026 vs 0. 684 ± 0. 012, P 〈 0.001 ). The migratory capability of ECV304 SKOV3 cells was 3.10 times that of ECV304 cells( P〈 0. 001 ). ECV304 -SKOV3 cells formed tubular structures more and longer than ECV304 calls did when co-cultured with SKOV3 cells( P 〈 0.01 ). L929 822 and L929 cell lines enhanced the invasiveness of human mammary cancer MDA MB 231 cells through artificial basement membrane (Matrigel) 1.21 and 0.48 respectively(P〈 0. 001). Fibroblasts L929-H22 stimulated endothelial cells to form more and longer tubes than L929 did( P〈 0.05 ), especially when L929 822 and ECV304 -SKOV3 cells were co - cultured. Conclusion : The results suggest that vascular endothelial cells and fibroblasts derived from tumors survive longer with greater ability to migrate and form tubes, and promote tumor cells invasion and vascular endothelial cells to form tubes, The two kinds of cells have a synergic role in the tumor angiogenesis.
出处 《重庆医科大学学报》 CAS CSCD 2005年第4期525-529,共5页 Journal of Chongqing Medical University
关键词 肿瘤 成纤维细胞 内皮细胞 血管形成 侵袭 Tumor Fibroblasts Endothelial cell Angiogcnesis Invasion
  • 相关文献

参考文献10

  • 1王小毅,任国胜,石远,汪毅,姚榛祥.透明质酸酶及肝素对血管生成影响的实验研究[J].重庆医学,2003,32(2):130-131. 被引量:4
  • 2use WJ.Hanrahan CF,Barrios RJ,et al.Angiogenesis and prostate cancer:identification of a molecular progression switch[J].Cancer Res,2001;61(6):2736-2743.
  • 3Olofsson B.Korpelainen E.Pepper MS,et al.Vascular endothclial growth factor B(VEGF-B)binds to VEGF receptor-I and regulates plasminogen activetor activity in endothclial cells[J].Proc Natl Acad Sci USA.1998;95(20):11709-11714.
  • 4Morimoto M, Irimura T. Fibroblast migratory factor derived from mouse colon carcinoma cells: potential roles of fibronectin in tumor stroma fomlation[J]. J Cell Biochem,2001 ;80(4) :635-646.
  • 5Bruns CJ, Liu W, Davis DW, et al. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a routine medel of colorectal carcinoma [ J ]. Cancer, 2000 ; 89(3) :488-499.
  • 6Pallini R, Pierconti F, Falchetti ML, et al. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors:expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells [J ]. J Neurosurg, 2001;94.(6):961 -971.
  • 7Waltenberger J, Claessonwelsh L, Siegbahn A, et al. Different signal transduction properties of KDR and Fit - 1, Two receptors for vascular endothelial growth factor [J]. J Biol Chem, 1994 ;269:26988-26995.
  • 8Asto Y. Transcription factor ETS 1 as a molecular target for angiogenesis inhibit ion [J].Hum Cell, 1998 ; 11 ( 4 ) : 207-214.
  • 9Croix BS, Rago C, Velculescu V, et al. Genes expression in human tumor endothelium [ J ]. Science, 2000; 289 : 1197 -1202.
  • 10Shekhar MPV,Werdell J,Santner SJ,et al. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implictions for tumor development and progression[ J ]. Cancer Res, 2001 ; 61 (4) : 1320 - 1326.

二级参考文献1

共引文献3

同被引文献9

  • 1陈平圣,尹克铮,韩月明,张晓明.利凡诺抗肿瘤作用初探[J].南京铁道医学院学报,1994,13(4):205-206. 被引量:2
  • 2王莉,陈平圣,冯珍.利凡诺对B16黑色素瘤细胞生长及MMP-2、MMP-9表达的影响[J].东南大学学报(医学版),2005,24(5):289-293. 被引量:1
  • 3陈平圣,尹克铮,韩月明.利凡诺对S—180实体瘤生长的影响[J].癌症,1996,15(3):184-185. 被引量:2
  • 4BYGDEMAN M,GEMZELL-DZNIELSSON K.An historical overview of second trimester abortion methods[J].Reprod Health Matters,2008,16(31):196-204.
  • 5DALVIE S S.Second trimester abortions in India[J].Reprod Health Matters,2008,16(31):37-45.
  • 6BOZA A V,de LEON R G,CASTILLO L S,et al.Misoprostol preferable to ethacridine lactate for abortions at 13-20 weeks of pregnancy:cuban experience[J].Reprod Health Matters,2008,16(31):189-195.
  • 7INAN I,KCLEKCI S,YAZAR D.Comparison of ethacridine lactate and prostaglandin E2 in second trimester medical abortion[J].Acta Obstet Gynecol Scand,1997,76(7):680-683.
  • 8BERG C,LUDWIG M,STURM N,et al.Intraamniotic ethacridine lactate instillation versus vaginal PGE1 in second trimester termination of pregnancy[J].Eur J Obstet Gynecol Reprod Biol,2006,126(2):193-196.
  • 9YAPAR E G,SENOZ S,UUKUTUR M,et al.Second trimester pregnancy termination including fetal death:comparison of five different methods[J].Eur J Obstet Gynecol Reprod Biol,1996,69(2):97-102.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部